WEIGHT LOSS

GLP-1 (Glucago like peptide) is a hormone your body natural makes. GLP-1 is released after you eat to make you feel full. GLP-1 also works to slow down the stomach from emptying to prevent you from eating more food. Semaglutide works by mimicking the actions of GLP-1, therefore you feel full longer and do not feel as hungry. In addition, Semaglutide works by activating GLP-1 receptors in the pancreas, resulting in the production and release of insulin, a hormone that helps the body to use glucose for energy. Semaglutide also helps to reduce the amount of glucose produced by the liver. Semaglutide is approved for weight loss management in men and women who qualify. Semaglutide is usually given as a small subcutaneous injection once a week in the belly fat. It has been shown to be very effective in weight loss and continued weight management.

As with any medication, Semaglutide may cause side effects. It is important for all members who are on therapy to familiarize themselves with the side effects of Semaglutide. This will help your provider and yourself commuicate about any symptoms you may encouter while on medication Nausea Diarrhea Vomiting Abdominal pain Constipation Headache Decreased appetite More serious side effects of Semaglutide may include: Pancreatitis (inflammation of the pancreas) Hypoglycemia (low blood sugar) Kidney problems Gallbladder problems Serious allergic reactions, including anaphylaxis Retinopathy (eye problems) Acute kidney injury Hypersensitivity reactions There are medications or supplements that have interactions with Semaglutide. It is important to notify your provider during your on boarding consultation of any medications you are taking to prevent an unwanted interaction.

Ozempic® is a brand name of medication that contains Semaglutide as the active ingredient. Both Ozempic® and Semaglutide have the same mechanism of action and work to treat the same conditions. They both work to i) increase the production of insulin in response to glucose, ii) slow down the rate at which food is absorbed from the gut, iii) reduce the amount of glucose produced by the liver iv) make you feel full and reduce food cravings. Furtheremore, Semaglutide and Ozempic® are different in the way they are administered. Semaglutide is available in different formulations, including oral tablets and injectable pens. Ozempic, on the other hand, is only available as an injectable pen. The main differences between them are in the way they are administered and their dosing.

If you miss a dose of Semaglutide (GLP-1), the following should be performed. Administer Semaglutide within 5 days after the missed dose. If more than 5 days have passed, it is ok to skip the missed dose and administer the next dose on the regularly scheduled day. In each case, resume regular once-weekly dosing schedule. If you have any questions please feel free to text your provider.

Semaglutide is a medication shown to reduce hunger, food cravings and appetite in men and women who qualify. For members who stop the medication foods craving are no longer reduced, and weight gain can rebound. Semaglutide is often taken indefinitely to maintain weight loss, yet some members are able to achieve a weight loss goal and maintain their weight off medication with a healthy diet and portion control.

1) Wegovy® and Ozempic® are approved for different indications of use. 2) Different types of patients are approved for Wegovy® and Ozempic® therapy. 3) Ozempic® and Wegovy® are branded medications that both contain the same active ingredient, Semaglutide, but at different dosages. 4) The side effects of Wegovy® and Ozempic® are relatively similar. Wegovy® and Ozempic® are both branded medications that have the same active ingredient Semaglutide, but are different in their indication for use and dosage protocols. Wegovy® and Ozempic® were studied in clinical trials for different indications and medical conditions. Ozempic® is FDA approved for type 2 diabetes management. Wegovy® is FDA approved for chronic weight management. In clinical trials adult patients on Wegovy® lost 15% of their body weight on average. In a separate trial, adolescent teens lost about 16% of their starting body weight on average. Wegovy can be titrated to a much higher dosage of 2.4mg weekly compared to Ozempic® highest dosage of 0.5mg weekly. Side effects of both medication are often related to gastro intestinal and digestion mediated symptoms.

Semaglutide starts to work the moment after you inject the first dose. It may take a few weeks or months before you notice weight loss or a decrease in appetite. This different per individual as results to the medication and response varies.

After an injection, Semaglutide will last in the body for approximately 5-7 days. This is one of the reasons why the medication is dose every 7 days.

The monthly membership at CURVI is 75$. The monthly membership includes the following: 1) The Initial onboarding consultation 2) Metabolic Lab Testing 3) 24/7 Physician Support 4) Quarterly Telehealth Visits 1) The initial onboarding consultation is with a board-certified physician who will i) review your medical intake form and medical history, ii) explain the risk and benefits of Semaglutide, iii) discuss and manage expectations of therapy, and iv) answer any questions you may have about weight loss therapy. 2) Metabolic laboratory testing may be required for certain members. Your physician will discuss if laboratory testing Is necessary prior to or during therapy. 3) The monthly membership includes access to your provider via phone text. Feel free during therapy if you have any questions or concerns to reach out. We want to ensure you are obtaining your weight loss goals and look out for your health. 4) The monthly membership includes quarterly Telehealth visits. The online visits may be via video or phone and are important to track weight loss measures, compliance with medication, and ensure your healthy and safety.

For CURVI members, the price for Semaglutide is only 299$. The fee includes all supplies, a multi-dose vial of Semaglutide (GLP-1), and overnight shipping. Members at CURVI can refill their medication anytime by simply texting their provider.

The multi-dose vial of Semaglutide (GLP-1) will last most members approximately 3 months. Medication dosage may change during treatment and may require refills to occur sooner. Your provider will review dosing protocols and the right dosage for you.

Currently, we are not contracted with any insurance companies and do not accept insurance payments. All payments for our services are made with a credit card. We do not accept cash or check payments.

CURVI is a monthly subscription service. Members will be billed monthly for 89$ while they are undergoing therapy. Medication is for members only and is a separate fee of 299$ per multi-dose vial of Semaglutide (GLP-1).

At CURVI we provide compounded medication that includes Tirzepatide and Semaglutide in a multidose vial. We do not provide Brand Name Wegovy® or Ozempic®. Wegovy® and Ozempic® are both brand names of medications that both contain Semaglutide (GLP-1) as their active ingredient. Wegovy® and Ozempic® have different indications for use as approved by the FDA and also contain different dosages of Semaglutide (GLP-1) in their delivery device.